CAROL MCCORMICK: Open Payments
NPI 1821004458 · SAN MARINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 39 payments from 16 companies in 2025. Trend: 2023 $761 · 2024 $956 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $165 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Bausch Health US, LLC | 2 | $35 |
Products named: VRAYLAR, COBENFY, HETLIOZ, CAPLYTA, UZEDY, Auvelity, INVEGA SUSTENNA, Jornay PM.
Industry payments across CA — which companies pay providers there.
